Write For Us

Psoriasis and beyond: targeting the IL-17 pathway

E-Commerce Solutions SEO Solutions Marketing Solutions
140 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

Danielle
Published
Psoriasis is a chronic inflammatory skin disorder that affects about 2-3% of the population. It is triggered by the immune system, and new insights into the immune processes have thrown up a number of exciting drug targets. This Nature Reviews Drug Discovery animation explores how the immune system goes awry in psoriasis and illustrates how agents that target the cytokine interleukin 17, or other players in the same pathway, are being developed into novel therapies for psoriasis.
Category
Documentary
Be the first to comment